October 2012 FDA Recall Lidocaine Hydrochloride by Hospira, Inc.
D-099-2013 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Hospira, Inc. on October 4, 2012 for the product Lidocaine Hydrochloride. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-099-2013

Reason for Recall
Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.
Initiated
10-04-2012
Reported
12-26-2012
Quantity
120,350 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.

Batch or Lot Expiration Information

Lot# : 14-277-DK*, Exp 02/01/14; * may be followed by 01